BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26856195)

  • 1. Smoking Cessation Support Services at Community Pharmacies in the UK: A Systematic Review.
    Peletidi A; Nabhani-Gebara S; Kayyali R
    Hellenic J Cardiol; 2016; 57(1):7-15. PubMed ID: 26856195
    [No Abstract]   [Full Text] [Related]  

  • 2. Status and costs of smoking cessation in countries of the Eastern Mediterranean Region.
    Heydari G; Talischi F; Mojgani N; Masjedi MR; Algouhmani H; Lando HA; Ahmady EA
    East Mediterr Health J; 2012 Nov; 18(11):1102-6. PubMed ID: 23301371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial IncEntives for Smoking TreAtment: protocol of the FIESTA trial and FIESTA Oral Microbiome Substudy.
    French KM; Gonzalez SZ; Sherman SE; Link AR; Malik SZ; Tseng CH; Jumkhawala SA; Tejada B; White A; Ladapo JA
    Trials; 2018 Nov; 19(1):646. PubMed ID: 30463608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking cessation in heart failure: it is never too late.
    Lightwood J; Fleischmann KE; Glantz SA
    J Am Coll Cardiol; 2001 May; 37(6):1683-4. PubMed ID: 11345384
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytisine, the world's oldest smoking cessation aid.
    Prochaska JJ; Das S; Benowitz NL
    BMJ; 2013 Aug; 347():f5198. PubMed ID: 23974638
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow.
    Boyd KA; Briggs AH
    Addiction; 2009 Feb; 104(2):317-25. PubMed ID: 19149829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking cessation.
    Gosney M
    Gerontology; 2001; 47(5):236-40. PubMed ID: 11490141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct observation of Medicaid beneficiary attempts to fill prescriptions for nicotine replacement medications.
    Richter KP; Shergina E; Grodie A; Massey JK; Ellerbeck EF; Applegate A; Faseru B
    J Am Pharm Assoc (2003); 2018; 58(4):432-437. PubMed ID: 29691198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis.
    Song F; Raftery J; Aveyard P; Hyde C; Barton P; Woolacott N
    Med Decis Making; 2002; 22(5 Suppl):S26-37. PubMed ID: 12369228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of the economic impact of smoking cessation in Europe.
    Cohen D; Alam MF; Jarvis PS
    BMC Public Health; 2013 Apr; 13():390. PubMed ID: 23617835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In defence of helping people to stop smoking.
    Britton J
    Lancet; 2009 Feb; 373(9665):703-5. PubMed ID: 19249617
    [No Abstract]   [Full Text] [Related]  

  • 12. Preparing for smoking cessation ahead of the ban.
    Wilkinson E
    Nurs Times; 2007 Jan 9-15; 103(2):23-4. PubMed ID: 17278730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-utility analysis of smoking cessation to prevent operative complications following elective abdominal colon surgery.
    Kulaylat AS; Hollenbeak CS; Soybel DI
    Am J Surg; 2018 Dec; 216(6):1082-1089. PubMed ID: 30262122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Life support.
    Donaldson SL
    Health Serv J; 2009 Sep; 119(6175):27. PubMed ID: 19877348
    [No Abstract]   [Full Text] [Related]  

  • 15. Economic impact of delays in listing decisions by provincial drug plans after a positive Common Drug Review recommendation: the case of a smoking-cessation treatment.
    Paradis PE; Mishagina N; Carter V; Raymond V
    Healthc Q; 2012; 15(2):52-60. PubMed ID: 22688206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Smoking and nicotine dependence].
    Pietilä K; Ahtee L
    Duodecim; 1999; 115(3):237-9. PubMed ID: 11830868
    [No Abstract]   [Full Text] [Related]  

  • 17. Brief interventions to reduce tobacco-related diseases.
    Hakesley-Brown R
    Nurs Stand; 2009 Mar 18-24; 23(28):43-7. PubMed ID: 19400369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Integrating Tobacco Cessation Into Post-Traumatic Stress Disorder Treatment.
    Barnett PG; Jeffers A; Smith MW; Chow BK; McFall M; Saxon AJ
    Nicotine Tob Res; 2016 Mar; 18(3):267-74. PubMed ID: 25943761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking cessation treatment in a public-health context.
    Warner KE; Mackay JL
    Lancet; 2008 Jun; 371(9629):1976-8. PubMed ID: 18555898
    [No Abstract]   [Full Text] [Related]  

  • 20. One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services.
    Bauld L; Boyd KA; Briggs AH; Chesterman J; Ferguson J; Judge K; Hiscock R
    Nicotine Tob Res; 2011 Feb; 13(2):135-45. PubMed ID: 21196451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.